Chris Maggos (Cohesion Bureau (brand of BioConfidant))

Maggos, Chris (BioConfidant / Cohesion Bureau 202303 Managing Director + Founder before LifeSci Advisors + Addex)

	Organisation	Cohesion Bureau (brand of BioConfidant)
	Group	BioConfidant (Group)
	Former/major organisation	LifeSci Advisors LLC
	Group	LifeSci (Group)
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

Record changed: 2024-10-07

Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x200px

More documents for Chris Maggos

[1] AC Immune S.A.. (12/15/23). "Press Release: AC Immune Announces Pricing of Underwritten Offering of Common Shares". Lausanne....
[2] EG 427. (7/13/23). "Press Release: EG 427 Announces Final Series A Closing, Achieving €18 Million in Total Funds Raised". Paris....
[3] AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne....
[4] Kinarus Therapeutics Holding AG. (8/22/22). "Press Release: Kinarus Announces the Issuance of Convertible Notes of up to CHF 20 Million to an Entity Managed by Yorkville [ not for any jurisdiction where unlawful]". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]